Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2018-05-01 Regulatory Filings
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2018
Regulatory Filings
2018-05-01 English
FORM S-1 AMENDMENT NO. 2
Regulatory Filings Classification · 100% confidence The document is titled 'Amendment No. 2 to FORM S-1' and is a Registration Statement filed with the SEC under the Securities Act of 1933. It includes detailed information about the company, its securities offering, selling stockholders, risk factors, use of proceeds, and other disclosures typical of a registration statement for an initial public offering or secondary offering. The presence of terms like 'prospectus,' 'shares of common stock,' 'selling stockholders,' and 'private placement' confirms this is a securities registration filing. Form S-1 and its amendments are used to register securities with the SEC and are not annual reports, earnings releases, or other types of filings listed in the classification scheme. The closest matching category is 'Regulatory Filings (RNS)' as this is a general regulatory filing that does not fit into other specific categories like Annual Report or Earnings Release. Therefore, the document should be classified as Regulatory Filings (RNS).
2018-04-17 English
FORM 10-Q
Interim / Quarterly Report Q2 2018
2018-04-16 English
Regulatory Filings 2018
Regulatory Filings
2018-04-06 English
Regulatory Filings 2018
Regulatory Filings
2018-03-27 English
FORM 10-Q AMENDMENT NO. 1
Interim / Quarterly Report Q1 2018
2018-03-21 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.